Swiss Industry Makes Breakthrough For Local Market Device Labeling
Rules on the labeling needs for medtech products entering the Swiss market have been eased in what is seen by the local industry as a victory for pragmatism.
You may also be interested in...
The EU’s full implementation of the In Vitro Diagnostic Regulation on 26 May has put the Swiss IVD industry on a "third country" footing with the EU, as happened in 2021 for medical devices. The two parties’ mutual recognition agreement for all medtech products has ceased to apply. A renewed MRA is not likely for several years.
3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum.
A scale-up strategy is the missing link in the UK devices industry, claims business research organization CPI. Own brand and contract medical manufacturer and packaging company Pennine Healthcare and longstanding medical device CDMO Renfrew Group International give their take on the environment for manufacturers and the opportunities for strengthening the industry base.